参考文献/References:
[1] Rizos T,Siegelin M,Hähnel S,et al.Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus(NPSLE)[J].Lupus,2009,18(4):361-363.
[2] Hochberg MC.Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus[J].Arthritis Rheum,1997,40(9):1725.
[3] 张真,肖岚,曾秋明,等.累及中枢神经系统的神经精神狼疮临床分析[J].中国现代神经疾病杂志,2013,13(1):43-48.
[4] Muscal E,Brey RL.Neurologic manifestations of systemic lupus erythematosus in children and adults[J].Neurol Clin,2010,28(1):61-73.
[5] Borhani Haghighi A,Haza SG.Neuropsychiatric manifestations of systemic lupus erythematosus: Iranian experience[J].Ann Indian Acad Neurol,2010,13(2):108-111.
[6] Yu HH,Wang LC,Lee JH,et al.Lymphopenia is associated with neuropsychiatric manifestations and disease activity in paediatric systemic lupus erythematosus patients[J].Rheumatology(Oxford),2007,46(9):1492-1494.
[7] Vil LM,Alarcón GS,Mcgwin G,et al.Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual[J].Arthritis Rheum,2006,55(5):799-806.
[8] Harirchian MH,Saberi H,Najafizadeh SR,et al.Evaluation of brain and cervical MRI abnormality rates in patients with systemic lupus erythematosus with or without neurological manifestations[J].Iranian Journal of Radiology,2011,8(3):157-160.
[9] Ng WL,Chu CM,Wu AK,et al.Lymphopenia at presentation is associated with increased risk of infections in patients with systemic lupus erythematosus[J].QJM,2006,99(1):37-47.
[10] Postal M,Costallat LT,Appenzeller S.Neuropsychiatric manifestations in systemic lupus erythematosus: epidemiology, pathophysiology and management[J].CNS Drugs,2011,25(9):721-736.
[11] Mok CC,Lau CS,Wong RW.Treatment of lupus psychosis with oral cyclophosphamide followed by azathioprine maintenance: an open-label study[J].Am J Med,2003,115(1):59-62.